NewAmsterdam Pharma Company NV Warrant
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $19,145 | $2,978 | $12,772 | $29,111 |
Gross Profit | 19,145 | 2,978 | 12,772 | 29,111 |
EBITDA | -35,590 | -68,873 | -111,693 | -23,840 |
EBIT | -35,635 | -68,925 | -111,744 | -23,868 |
Net Income | -17,364 | -39,527 | -92,177 | -16,647 |
Net Change In Cash | 19,145 | 2,978 | 12,772 | 29,111 |
Free Cash Flow | -37,759 | -36,484 | -37,484 | -12,577 |
Cash | 563,864 | 748,420 | 771,743 | 422,729 |
Basic Shares | 112,509 | 116,124 | 97,028 | 94,754 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $45,563 | $12,762 | $95,905 | $0 |
Gross Profit | 45,563 | 12,762 | 95,905 | -14 |
EBITDA | -241,486 | -176,861 | -3,313 | -30,726 |
EBIT | -241,599 | -176,910 | -3,321 | -30,730 |
Net Income | -241,598 | -176,937 | -21,137 | -36,712 |
Net Change In Cash | 45,563 | 12,762 | 95,905 | 0 |
Free Cash Flow | -159,236 | -141,242 | 7,959 | -25,184 |
Cash | 771,743 | 340,450 | 438,522 | 53,092 |
Basic Shares | 94,358 | 82,161 | 18,966 | 17,751 |
